News US authorities probe marketing of J&J drugs US authorities suspicious over marketing, rebates and payment support programmes.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News After healthcare defeat, markets fear Trump's tax plans will... Trump could use executive powers to undermine system.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
